Urticaria
Conditions
Interventions
Warfarin
Sponsors
Department of Dermatology, Integrated Health Sciences, Institute of Biomedical & Health Sciences, Hiroshima University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: A) Patients who are suffuring from urticaria and are 20 years old or more and less than 70 years old. B) Patients who are insufficiently controlled by standard therapies, or are not able to use standard medicines due to the adverse effects. C) Patients who can come to our outpatient clinic. D) Patients who can give consent in writing.
Exclusion criteria
Exclusion criteria: A) Patiets who take medical agents that influence on coagulation system. B) Bleeding patients. C) Patients who has the risks of bleeding. E) Patients who are recently operated or injured. F) Patients who previously had the adverse drug reaction against warfarin. And patients who can not stop taking medications which show drug interaction with warfarin. G) Patients who are pregnant or have chance of pregnancy. H) Patients who are medicated by vitamineK. I) Patiens who are pegged as unsuitable for this study by their doctor. J) Patients who has the potential of injury or contused wound by heavy exercise or work.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms and Urticarial scores before and after taking warfarin | — |
Countries
Japan
Contacts
Public ContactSatoshi Morioke
Hiroshima University Hospital Department of Dermatology
Outcome results
None listed